Weekly Recap | AstraZeneca +1.47%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 06:08 AMAZN+0.26%
Weekly Recap | VG Value +1.55%, low-volatility grind higherWeekly Review·Oct 10, 2026 at 05:00 AMVTV+0.44%
Weekly Recap | AIM ImmunoTech -5.31%, consensus target above spotWeekly Review·Oct 3, 2026 at 06:16 AMAIM+0.22%
Weekly Recap | AIM ImmunoTech -11.92%, patent estate adds oncology and Long COVID coverageWeekly Review·Sep 5, 2026 at 06:04 AMAIM+0.22%
